Minimally invasive aortic valve surgery or TAVI: The need for randomised trials
Minimally invasive aortic valve replacement (miAVR) in select patients with severe aortic stenos...
ADVERTORIAL: What does SCOPE II tell us about TAVI device trials?
This advertorial is sponsored by Boston Scientific
Results of the SCOPE II clinical trial wer...
Sharing international insight to improve the cardiovascular treatment pathway
Michael Poon (Lenox Hill Hospital-Northwell Health, New York, USA) discusses the progress made in tr...
Optimising pharmacology after transcatheter aortic valve replacement: Lessons from the POPular TAVI trial
Writing for Cardiovascular News, Harold Dauerman, Rony Lahoud and Newton Phuong from the Univers...
